title: Radiologists urge FDA to accept PET-based tumor response criteria in clinical trials.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D002986:Clinical Trials as Topic / Q000379:methods*; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008223:Lymphoma / Q000000981:diagnostic imaging; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000378:metabolism; D009683:Nuclear Medicine / Q000639:trends*; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000378:metabolism; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D000078329:Workforce
chemical_list: D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18